Dr Christopher Jones Dr Andrew Hughes
| Prophylactic cranial irradiation (PCI) in extensive stage small cell lung cancer (ED-SCLC): a retrospective review of practice at the Northern Centre for Cancer Treatment | 2009 |
|
Dr Ashraf Azzabi Dr Andrew Hughes Dr Paula Calvert Professor Ruth Plummer Melanie Griffin et al. | Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations | 2005 |
|
Professor Alan Boddy Gordon Taylor Dr Andrew Hughes Professor Alan Calvert Professor Herbie Newell et al. | 2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337 | 2003 |
|
Professor Ruth Plummer Dr Andrew Hughes Dr Martin Highley Dr Sathyarathna Gokul Professor Alan Calvert et al. | A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor | 2003 |
|
Simon Cox Andrew Critchley Dr Andrew Hughes Faye Kemp Dr Iain McNab et al. | Coaxial ion beam/infrared laser beam spectrometer for investigating infrared spectra of doubly positively charged molecules (molecular dications) | 2002 |
|
Dr Andrew Hughes Dr Paula Calvert Dr Ashraf Azzabi Professor Ruth Plummer Melanie Griffin et al. | Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma | 2002 |
|
Dr Andrew Hughes Dr Ashraf Azzabi Professor Ruth Plummer Dr Jane Margetts Kevin Fishwick et al. | A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta (R), multitargeted antifolate). | 2001 |
|
Professor Nicola Curtin Dr Andrew Hughes
| Pemetrexed disodium, a novel antifolate with multiple targets | 2001 |
|
Dr Paula Calvert Dr Ashraf Azzabi Dr Andrew Hughes Professor Ruth Plummer Angela Robinson et al. | A phase I clinical and pharmacokinetic study of EPO906 (epothilone B) in patients with advanced solid tumours. | 2000 |
|
Dr Andrew Hughes Melanie Griffin Professor Herbie Newell Professor Alan Calvert Professor Alan Boddy et al. | Clinical pharmacokinetic and in vitro combination studies of nolatrexed dihydrochloride (AG337, Thymitaq(TM)) and paclitaxel | 2000 |
|
Dr Andrew Hughes Professor Alan Calvert
| An update on thymidylate synthase inhibitors | 1999 |
|
Dr Andrew Hughes Melanie Griffin Professor Alan Calvert Professor Herbie Newell Professor Alan Boddy et al. | Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 days | 1999 |
|
Dr Andrew Hughes Melanie Griffin Professor Alan Calvert Andrew Johnston Professor Herbie Newell et al. | Pharmacokinetic interactions in a phase I study of nolatrexed (AG337, THYMITAQ TM) and paclitaxel in patients with advanced solid tumours | 1998 |
|
Professor Alan Calvert Professor Alan Boddy Dr Andrew Hughes Lynsey Robson Huw Thomas et al. | Carboplatin in combination with paclitaxel in advanced ovarian cancer: dose determination and pharmacokinetic and pharmacodynamic interactions. | 1995 |
|